|
Re: Patient Enrollment Modeling
|
5
|
Resverlogix Corp.
|
Dec 02, 2018 12:58PM
|
|
Re: Hold or fold?
|
5
|
Resverlogix Corp.
|
Dec 17, 2020 05:38PM
|
|
Re: HOW LONG
|
5
|
Resverlogix Corp.
|
Jul 27, 2022 11:02AM
|
|
Re: Article on NASH Liver Disease
|
5
|
Resverlogix Corp.
|
Aug 18, 2019 03:53AM
|
|
Re: Two articles - Apabetalone for Colon Cancer?
|
5
|
Resverlogix Corp.
|
Jul 09, 2021 12:26PM
|
|
Re: Earliest minute/hour
|
5
|
Resverlogix Corp.
|
Sep 29, 2019 02:51PM
|
|
Is this bad for RVX but right, on the money?
|
5
|
Resverlogix Corp.
|
Apr 18, 2020 05:15PM
|
|
Re: what are the chances?
|
5
|
Resverlogix Corp.
|
Mar 24, 2022 03:23PM
|
|
Re: Why are you invested in RVX
|
5
|
Resverlogix Corp.
|
Jun 18, 2019 04:25PM
|
|
Re: The last DSMB update of Feb 26th....
|
5
|
Resverlogix Corp.
|
Jun 24, 2018 11:56PM
|
|
Re: Buyout?......
|
5
|
Resverlogix Corp.
|
Jun 02, 2019 10:54AM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:43PM
|
|
Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
|
5
|
Zenith Epigenetics
|
Feb 05, 2019 09:14PM
|
|
Happy Thanksgiving
|
5
|
Resverlogix Corp.
|
Nov 26, 2020 02:53PM
|
|
Re: Will we see 5 point MACE reduction results in BETONMACE
|
5
|
Resverlogix Corp.
|
Jun 18, 2019 06:13PM
|
|
Zenith share issue
|
5
|
Zenith Epigenetics
|
Nov 13, 2017 11:10PM
|
|
Re: The Feb 26th DSMB PR.....re-examined.
|
5
|
Resverlogix Corp.
|
May 14, 2018 11:09PM
|
|
Re: The last DSMB update of Feb 26th....
|
5
|
Resverlogix Corp.
|
Jun 25, 2018 12:42AM
|
|
Re: Finance
|
5
|
Resverlogix Corp.
|
May 26, 2020 12:54AM
|
|
Re: ... unfinished business
|
5
|
Zenith Epigenetics
|
Nov 02, 2018 03:03AM
|
